SCHEMBL12018761

SCHEMBL12018761

Cc1ccc(-c2cc3c(C)ccc4c5cc(-c6ccc(Oc7ccccc7)cc6)cc6c(C)ccc(c(c2)c34)c65)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ FFAR4 Q5NUL3 1/20 0.40
▸ GSTP1 P09211 1/20 0.39
▸ LTA4H P09960 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ AKR1C3 P42330 2/20 0.37
▸ AKR1C2 P52895 1/20 0.37
▸ ERN1 O75460 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MCL1 Q07820 3/20 0.36
▸ TEAD4 Q15561 1/20 0.36
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12018762 1.00 HTT (0.43) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL12018759 0.83 ACHE (0.48) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL12018760 0.83 ACHE (0.48) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL24322042 0.79 HTT (0.62) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL20419433 0.79 HTT (0.62) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL822790 0.79 HTT (0.62) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL24871259 0.76 HTT (0.50) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL537243 0.75 HTT (0.57) HTTSMN1; SMN2FFAR4GSTP1LTA4H
SCHEMBL2058591 0.75 HTT (0.57) HTTSMN1; SMN2FFAR4GSTP1LTA4H
Diphenylether SCHEMBL9751563 0.75 LTA4H (0.57) HTTSMN1; SMN2FFAR4GSTP1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120217445-A1 POLYMER COMPOUND AND METHOD FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120217445-A1 POLYMER COMPOUND AND METHOD FOR PRODUCING THE SAME PUF60, PARG, PCBP1 HTT 2734/4885SMN1; SMN2 1707/4885FFAR4 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback